Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarantus Bioscience Holdings Inc (OTCQB:AMBS)

During the Trading Day
0.0548 +0.0028 / +5.38%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.0505 -0.0043 / -7.85%
Volume: --
Health Technology

Company Description

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.

Contact Information

Amarantus Bioscience Holdings, Inc.
655 Montgomery Street
San Francisco California 94111
P:(415) 688-4484
Investor Relations:



Individual stakeholders0.29%
Mutual fund holders--
Other institutional--

Top Executives

Gerald E. CommissiongPresident, Chief Executive Officer & Director
Elise BrownellSenior VP-Operations & Program Management
John W. CommissiongDirector & Chief Scientific Officer
Marc E. FaerberSecretary, Treasurer & Controller
Curtis L. ScribnerSenior Vice President-Regulatory Affairs